Total Payments
$4,957
2024 Payments
$770.44
Companies
10
Transactions
21
Medicare Patients
18
Medicare Billing
$887.04
Payment Breakdown by Category
Other$2,500 (50.4%)
Research$1,341 (27.1%)
Food & Beverage$1,116 (22.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,850 | 2 | 37.3% |
| Unspecified | $1,341 | 5 | 27.1% |
| Food and Beverage | $1,116 | 13 | 22.5% |
| Honoraria | $650.00 | 1 | 13.1% |
Payments by Type
General
$3,616
16 transactions
Research
$1,341
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,850 | 2 | $0 (2020) |
| Regeneron Pharmaceuticals, Inc. | $1,341 | 5 | $0 (2019) |
| ALK-Abello, Inc | $650.00 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $378.43 | 5 | $0 (2023) |
| Bio Products Laboratory USA, Inc. | $150.72 | 1 | $0 (2018) |
| Shire North American Group Inc | $146.34 | 3 | $0 (2018) |
| Circassia Pharmaceuticals Inc | $142.03 | 1 | $0 (2018) |
| BioCryst US Sales Co., LLC | $123.43 | 1 | $0 (2021) |
| Genentech USA, Inc. | $120.44 | 1 | $0 (2024) |
| Eurofins Viracor, Inc. | $54.19 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $770.44 | 2 | ALK-Abello, Inc ($650.00) |
| 2023 | $75.77 | 1 | AstraZeneca Pharmaceuticals LP ($75.77) |
| 2021 | $177.62 | 2 | BioCryst US Sales Co., LLC ($123.43) |
| 2020 | $1,850 | 2 | PFIZER INC. ($1,850) |
| 2019 | $1,479 | 7 | Regeneron Pharmaceuticals, Inc. ($1,341) |
| 2018 | $500.36 | 5 | AstraZeneca Pharmaceuticals LP ($164.62) |
| 2017 | $103.35 | 2 | Shire North American Group Inc ($103.35) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $120.44 | General |
| Category: Immunology | ||||||
| 07/22/2024 | ALK-Abello, Inc | Grastek (Drug), Odactra, Ragwitek | Honoraria | Cash or cash equivalent | $650.00 | General |
| Category: Allergy and Immunology | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $75.77 | General |
| Category: Respiratory | ||||||
| 07/27/2021 | BioCryst US Sales Co., LLC | Orladeyo (Drug) | Food and Beverage | In-kind items and services | $123.43 | General |
| Category: Immunology | ||||||
| 07/21/2021 | Eurofins Viracor, Inc. | — | Food and Beverage | Cash or cash equivalent | $54.19 | General |
| 07/20/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $370.00 | General |
| 05/04/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| 04/18/2019 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | — | In-kind items and services | $71.20 | Research |
| Study: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 Peanut Oral Immunotherapy • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/18/2019 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | — | In-kind items and services | $35.57 | Research |
| Study: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 Peanut Oral Immunotherapy • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/30/2019 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | — | In-kind items and services | $985.44 | Research |
| Study: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 Peanut Oral Immunotherapy • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/30/2019 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | — | In-kind items and services | $128.99 | Research |
| Study: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 Peanut Oral Immunotherapy • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/29/2019 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | — | In-kind items and services | $119.99 | Research |
| Study: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 Peanut Oral Immunotherapy • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/22/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $104.67 | General |
| 01/22/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: Respiratory | ||||||
| 10/03/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $94.89 | General |
| 09/11/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $69.73 | General |
| Category: Respiratory | ||||||
| 05/07/2018 | Shire North American Group Inc | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $42.99 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO | Food and Beverage | In-kind items and services | $142.03 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 03/01/2018 | Bio Products Laboratory USA, Inc. | Gammaplex (Drug) | Food and Beverage | In-kind items and services | $150.72 | General |
| Category: IVIG | ||||||
| 03/04/2017 | Shire North American Group Inc | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2017 | Shire North American Group Inc | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $80.54 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 Peanut Oral Immunotherapy | Regeneron Pharmaceuticals, Inc. | $1,341 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 18 | 490 | $22,160 | $887.04 |
Total Patients
18
Total Services
490
Medicare Billing
$887.04
Procedure Codes
1
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Facility | 2021 | 18 | 490 | $22,160 | $887.04 | 4.0% |
About Dr. Malika Gupta, M.D
Dr. Malika Gupta, M.D is a Pediatrics healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1467618520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malika Gupta, M.D has received a total of $4,957 in payments from pharmaceutical and medical device companies, with $770.44 received in 2024. These payments were reported across 21 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,850).
As a Medicare-enrolled provider, Gupta has provided services to 18 Medicare beneficiaries, totaling 490 services with total Medicare billing of $887.04. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatrics, Pediatric Allergy/Immunology
- Location Ann Arbor, MI
- Active Since 07/29/2008
- Last Updated 12/29/2023
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1467618520
Products in Payments
- DUPIXENT (Biological) $1,341
- Grastek (Drug) $650.00
- Gammaplex (Drug) $150.72
- CUVITRU (Biological) $146.34
- TUDORZA PRESSAIR (Drug) $142.03
- Orladeyo (Drug) $123.43
- Xolair (Biological) $120.44
- FASENRA (Drug) $103.10
- TEZSPIRE (Biological) $75.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Ann Arbor
Jordan Shavit, Md, MD
Pediatrics — Payments: $209,597
Pediatrics $209,597
Dr. Jeffrey Zampi, Md, MD
Pediatrics — Payments: $188,895
Pediatrics $188,895
Steven Donn, Md, MD
Pediatrics — Payments: $113,934
Pediatrics $113,934
Andrew Campbell, Md, MD
Pediatrics — Payments: $96,431
Pediatrics $96,431
Maysa Hamade, M.d, M.D
Pediatrics — Payments: $90,101
Pediatrics $90,101
David Svilar
Pediatrics — Payments: $66,000
Pediatrics $66,000